title: Genetic regulation of alpha-synuclein mRNA expression in various human brain tissues.
abstract: Genetic variability across the SNCA locus has been repeatedly associated with susceptibility to sporadic Parkinson's disease (PD). Accumulated evidence emphasizes the importance of SNCA dosage and expression levels in PD pathogenesis. However whether genetic variability in the SNCA gene modulates the risk to develop sporadic PD via regulation of SNCA expression remained elusive. We studied the effect of PD risk-associated variants at SNCA 5' and 3'regions on SNCA-mRNA levels in vivo in 228 human brain samples from three structures differentially vulnerable to PD pathology (substantia-nigra, temporal- and frontal-cortex) obtained from 144 neurologically normal cadavers. The extensively characterized PD-associated promoter polymorphism, Rep1, had an effect on SNCA-mRNA levels. Homozygous genotype of the 'protective', Rep1-259 bp allele, was associated with lower levels of SNCA-mRNA relative to individuals that carried at least one copy of the PD-risk associated alleles, amounting to an average decrease of approximately 40% and >50% in temporal-cortex and substantia-nigra, respectively. Furthermore, SNPs tagging the SNCA 3'-untranslated-region also showed effects on SNCA-mRNA levels in both the temporal-cortex and the substantia-nigra, although, in contrast to Rep1, the 'decreased-risk' alleles were correlated with increased SNCA-mRNA levels. Similar to Rep1 findings, no difference in SNCA-mRNA level was seen with different SNCA 3'SNP alleles in the frontal-cortex, indicating there is brain-region specificity of the genetic regulation of SNCA expression. We provide evidence for functional consequences of PD-associated SNCA gene variants in disease relevant brain tissues, suggesting that genetic regulation of SNCA expression plays an important role in the development of the disease.
authors.affiliation: Institute for Genome Sciences & Policy, Duke University Medical Center, Durham, North Carolina, United States of America.
authors.forename: Colton
authors.initials: C
authors.lastname: Linnertz
authors.forename: Laura
authors.initials: L
authors.lastname: Saucier
authors.forename: Dongliang
authors.initials: D
authors.lastname: Ge
authors.forename: Kenneth D
authors.initials: KD
authors.lastname: Cronin
authors.forename: James R
authors.initials: JR
authors.lastname: Burke
authors.forename: Jeffrey N
authors.initials: JN
authors.lastname: Browndyke
authors.forename: Christine M
authors.initials: CM
authors.lastname: Hulette
authors.forename: Kathleen A
authors.initials: KA
authors.lastname: Welsh-Bohmer
authors.forename: Ornit
authors.initials: O
authors.lastname: Chiba-Falek
mesh_terms: D000368:Aged; D001921:Brain / Q000378:metabolism*; D005260:Female; D005625:Frontal Lobe / Q000378:metabolism; D005786:Gene Expression Regulation; D005787:Gene Frequency; D006801:Humans; D008297:Male; D008636:Mesencephalon / Q000378:metabolism; D008875:Middle Aged; D011149:Pons / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism*; D013378:Substantia Nigra / Q000378:metabolism; D013702:Temporal Lobe / Q000378:metabolism; D014018:Tissue Distribution; D051844:alpha-Synuclein / Q000096:biosynthesis*
chemical_list: D012333:RNA, Messenger; D051844:alpha-Synuclein